Current role
J. Jill Hopkins, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About J. Jill Hopkins, M.D.
Aura Biosciences, Inc. reported in an 8-K filed October 2, 2023 that J. Jill Hopkins, M.D. was appointed Chief Medical Officer and President of Research & Development, effective October 16, 2023.
“On October 2, 2023, Aura Biosciences, Inc. (the "Company") announced that J. Jill Hopkins, M.D., will serve as the Company's Chief Medical Officer and President of Research & Development, effective as of October 16, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aura Biosciences, Inc. (AURA)
SEC 8-K
Current2023-10-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aura Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Elisabet de los Pinos CEO, Board Member
- Natalie Holles CEO, Board Member
- Amy Elazzouzi CFO, Chief Accounting Officer
- Anthony Gibney CFO
- Julie B. Feder CFO
- Susan Abu-Absi COO
- Mark Plavsic CTO
- Conor Kilroy General Counsel
- David Johnson Board Member
- Jeremy Bender, Ph.D., M.B.A. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.